Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus Roll-over Protocol
NCT01789281Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2013
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 4 trial of everolimus in Neoplasm, sponsored by Novartis. Started May 2013; status: completed.
02
Drugs
everolimus
03
Conditions
Neoplasm
Beyond the preview
Go deeper on NCT01789281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01789281.